Ascendia Pharmaceutical Solutions
(formerly Ascendia® Pharmaceuticals, Ascendia® Pharma)
661 US Highway One, Unit B
North Brunswick, NJ 08902
T: (732) 638-4028
E: bd@ascendiacdmo.com
W: www.ascendiacdmo.com
Company Description
In only a decade, Ascendia Pharmaceutical Solutions has evolved from a specialty formulation research organization to a valued CDMO partner that provides comprehensive solutions from pre-formulation through to commercialization. Ascendia Pharmaceutical Solutions has become a Partner of Choice by consistently making the Impossible Possible through its experienced scientific teams, proprietary nanotechnologies, and advanced manufacturing capabilities.
Its comprehensive services are used in a variety of drug development initiatives for small molecules, as well as biologics and gene deliveries. Ascendia Pharmaceutical Solutions addresses evolving market needs, including lipid nanoparticles (LNPs), through the simple elegance of its nanotechnologies and sophisticated processes, such as lyophilization, that result in overcoming drug development challenges where others have failed. This includes the ability to optimize dosage forms, allowing drugs to be delivered in new ways, for the well-being of patients.
Pharmaceutical and biotech companies partner with Ascendia Pharmaceutical Solutions from discovery through commercialization because all GRAS (Generally Regarded As Safe) materials are used, so drugs can be brought to market on time, cost efficiently, and in dosage forms previously unattainable.
Company Background
Founded in 2012, the company offers a comprehensive suite of pre-formulation, formulation development, cGMP manufacturing, and ICH stability services for all dosage forms. Ascendia Pharmaceutical Solutions built its foundation of success on its customer-centric culture that exudes its BEST philosophy (Brilliant technology, Excellent service, Superior quality, and Trust). This approach has led to Ascendia Pharmaceutical Solutions doubling in size in the past three years and being named to the prestigious Inc. 5000 list four consecutive years.
Markets Served/Facilities
Ascendia Pharmaceutical Solutions is headquartered in the New Jersey Bioscience Center, North Brunswick, NJ. Its 60,000 square-foot facility has Class 10,000 (ISO 7) and Class 100 (ISO 5) cleanrooms, as well as Class 100,000 (ISO 8) manufacturing suites. It provides custom sterile and non-sterile enabling formulations, along with analytical methods for new chemical entities, complex dosage forms, and 505(B)(2) product development, as well as OTCs, veterinary drugs, and nutraceuticals.
Products, Services & Capabilities
Ascendia Pharmaceutical Solutions delivers sophisticated formulations to enhance bioavailability and solubility using four proprietary nanotechnologies – AmorSol®, EmulSol®, LipidSol®, and NanoSol®. Its state-of-the-art facility supports GLP and cGMP manufacturing in accordance with ICH guidelines.
Drug development teams rely on Ascendia Pharmaceutical Solutions for:
Posted Date: 12/1/2024
This record has been viewed 362 times.